Accuray Asia Ltd. and a subsidiary of China Isotope and Radiation Corp. (CIRC) have formed a joint venture (JV) to manufacture and sell radiation oncology systems in China. Joshua Levine, president and CEO of Sunnyvale, Calif.-based Accuray Inc., noted that the JV's unveiling followed an 18-month evaluation process. "We believe that . . . the JV will be ideally positioned to effectively address unmet patient needs and improve lives in the world's largest market for radiation oncology."